ATE287707T1 - Injizierbare propofol-formulierungen - Google Patents

Injizierbare propofol-formulierungen

Info

Publication number
ATE287707T1
ATE287707T1 AT99936010T AT99936010T ATE287707T1 AT E287707 T1 ATE287707 T1 AT E287707T1 AT 99936010 T AT99936010 T AT 99936010T AT 99936010 T AT99936010 T AT 99936010T AT E287707 T1 ATE287707 T1 AT E287707T1
Authority
AT
Austria
Prior art keywords
formulations
propofol
injectable
methylpyrrolidone
useful
Prior art date
Application number
AT99936010T
Other languages
English (en)
Inventor
Gene Komer
Original Assignee
Veterinary Res Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veterinary Res Associates Inc filed Critical Veterinary Res Associates Inc
Application granted granted Critical
Publication of ATE287707T1 publication Critical patent/ATE287707T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99936010T 1998-07-31 1999-07-30 Injizierbare propofol-formulierungen ATE287707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/127,082 US5962536A (en) 1998-07-31 1998-07-31 Injectable propofol formulations
PCT/US1999/017433 WO2000006142A1 (en) 1998-07-31 1999-07-30 Injectable propofol formulations

Publications (1)

Publication Number Publication Date
ATE287707T1 true ATE287707T1 (de) 2005-02-15

Family

ID=22428216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936010T ATE287707T1 (de) 1998-07-31 1999-07-30 Injizierbare propofol-formulierungen

Country Status (10)

Country Link
US (1) US5962536A (de)
EP (1) EP1131062B1 (de)
JP (1) JP2002521434A (de)
AT (1) ATE287707T1 (de)
AU (1) AU755613B2 (de)
CA (1) CA2338684C (de)
DE (1) DE69923471T2 (de)
ES (1) ES2237132T3 (de)
NZ (1) NZ510469A (de)
WO (1) WO2000006142A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
CA2459125A1 (en) 2001-09-26 2003-04-03 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
AU2003226324A1 (en) * 2002-04-10 2003-10-27 Verification Technologies, Inc. Content replication deterrent method on optical discs
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
BR0313060A (pt) * 2002-07-29 2005-06-28 Transform Pharmaceuticals Inc Composições farmacêuticas aquosas de 2,6-diisopropilfenol
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AU2003286725B2 (en) * 2002-10-29 2007-07-12 Transform Pharmaceuticals, Inc. Propofol with cysteine
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
WO2004108113A1 (en) * 2003-06-10 2004-12-16 Dinesh Shantilal Patel Improved novel, clear, painless preparation of propofol
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US20050163718A1 (en) * 2004-01-23 2005-07-28 Shugart Jack I. Injectable euthanasia compositions that include a taste aversive agent
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
CA2645070C (en) * 2006-03-08 2014-02-04 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
JP5529539B2 (ja) * 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
EP2191827B1 (de) 2007-09-05 2013-10-30 Pola Pharma Inc. Antimykotische zusammensetzung
CN101808639B (zh) * 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
TW200922585A (en) * 2007-10-26 2009-06-01 Astrazeneca Ab Amino 1,2,4-triazole derivatives as modulators of mGluR5
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
EP2416757A2 (de) 2009-04-09 2012-02-15 Pola Pharma Inc. Antimykotische pharmazeutische zusammensetzung
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN107049936B (zh) * 2017-04-17 2018-11-23 南京健友生化制药股份有限公司 含防腐剂的苯磺顺阿曲库铵注射液的放大生产方法
US20230086729A1 (en) * 2021-08-27 2023-03-23 Slayback Pharma Llc Stable pharmaceutical compositions of succinylcholine chloride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof

Also Published As

Publication number Publication date
JP2002521434A (ja) 2002-07-16
WO2000006142A1 (en) 2000-02-10
ES2237132T3 (es) 2005-07-16
US5962536A (en) 1999-10-05
AU755613B2 (en) 2002-12-19
EP1131062A1 (de) 2001-09-12
DE69923471D1 (de) 2005-03-03
EP1131062A4 (de) 2002-07-03
EP1131062B1 (de) 2005-01-26
AU5136899A (en) 2000-02-21
CA2338684A1 (en) 2000-02-10
DE69923471T2 (de) 2006-03-30
CA2338684C (en) 2006-02-14
NZ510469A (en) 2002-12-20

Similar Documents

Publication Publication Date Title
ATE287707T1 (de) Injizierbare propofol-formulierungen
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
EE9900156A (et) Kondenseerunud 1-bensüül-3-(asendatud heteroarüül)pürasooli derivaadid
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
BR0317822A (pt) Composição fluoroquìmica
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
DE59906975D1 (de) Wässrige reaktive spachtelmassen (i)
BR9709551A (pt) Composicões de limpeza ácidas contendo goma de xantano
ES2195970T3 (es) L-ribavirina y usos de la misma.
ATE251108T1 (de) Compositionen auf basis von resveratrolderivaten
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
BR9806296B1 (pt) compostos de ácido sulfìnico, mistura, composição e uso dos mesmos.
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
BR9801652A (pt) Resorcinil-triazinas
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
SE9602818D0 (sv) Colored composition
ATE428403T1 (de) Stabilisierte azithromycin-zusammensetzungen
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
DK1330258T3 (da) Kahalalid F-formulering
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
ATE391488T1 (de) Haarfärbezusammensetzungen auf basis von diaminopyrazolverbindungen
BR9903585A (pt) Composição de borracha que contém material anti-reversão e pneu com com componente da mesma
BR0116152B1 (pt) aditivo adequado para uso como emulsificador e solubilizador, uso de um aditivo, e, composição.
EA199800534A1 (ru) ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ
BG100248A (bg) Инхибитори на скваленсинтетаза

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties